Gregory Lawrence Verdine

USPTO Granted Patents = 84 (Patent Applications = 46)

CIPO Patents = 8 (Patent Applications = 16)

EPO Patents = 18 (Patent Applications = 36)

Average Co-Inventor Count = 3.3

ph-index = 27

Forward Citations = 2,014(Granted Patents)

Forward Citations (Not Self Cited) = 1,589(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Somerville, MA (US) (1998)
Cambridge, MA (US) (2002 - 2006)
Lexington, MA (US) (2000 - 2016)
Bedford, MA (US) (2018)
Newton, MA (US) (2007 - 2019)
Boston, MA (US) (2015 - 2024)

Company Filing History:

Wave Life Sciences Ltd.

patents

8 out of 1,206

Dana-farber-cancer Institute Inc.

Revolution Medicines, Inc.

Ginkgo Bioworks, Inc.

patents

8. 2 out of 2

Fog Pharmaceuticals, Inc.

patents

9. 2 out of 2

Lifemine Therapeutics, Inc.

Aileron Therapeutics, Inc.

Parabilis Medicines, Inc.

patent

16. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

84 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12398178 - Collections of peptides, peptide agents, and methods of use thereof (2025-08-26),

2. 12258423 - Stapled and stitched polypeptides and uses thereof (2025-03-25),

3. 12243623 - Human therapeutic targets and modulators thereof (2025-03-04),

4. 12180472 - Chiral design (2024-12-31),

5. 11987590 - Compounds that participate in cooperative binding and uses thereof (2024-05-21),

6. 11834482 - Agents modulating beta-catenin functions and methods thereof (2023-12-05),

7. 11749375 - Human therapeutic targets and modulators thereof (2023-09-05),

8. 11644460 - Identifying new therapeutic agents (2023-05-09),

9. 11643657 - Chiral control (2023-05-09),

10. 11479797 - Compositions and methods for the production of compounds (2022-10-25),

11. 11447810 - Compositions and methods for the production of compounds (2022-09-20),

12. 11377476 - Ras inhibitory peptides and uses thereof (2022-07-05),

13. 11332496 - Stapled and stitched polypeptides and uses thereof (2022-05-17),

14. 11198713 - Agents modulating beta-catenin functions and methods thereof (2021-12-14),

15. 11059830 - Compounds that participate in cooperative binding and uses thereof (2021-07-13),

Title: The Innovative Journey of Gregory Lawrence Verdine

Introduction:

Gregory Lawrence Verdine is a distinguished inventor hailing from Boston, MA. His groundbreaking work in the field of biotechnology has revolutionized the way we approach drug discovery and development.

Latest Patents:

Gregory Lawrence Verdine holds several patents in the biotechnology sector, focusing on novel therapeutic approaches and innovative drug delivery systems. His patents showcase his commitment to pushing the boundaries of science and technology.

Career Highlights:

With a stellar academic background and extensive experience in the biotech industry, Gregory Lawrence Verdine has made significant contributions to the field. He has held key positions in renowned research institutions and biopharmaceutical companies, shaping the future of medicine.

Collaborations:

Throughout his career, Gregory Lawrence Verdine has collaborated with leading scientists, researchers, and industry experts to drive innovation and bring cutting-edge therapies to the market. His collaborative spirit has led to the development of groundbreaking technologies with far-reaching implications.

Conclusion:

In conclusion, Gregory Lawrence Verdine stands as a visionary inventor whose work continues to inspire and shape the landscape of biotechnology. His relentless pursuit of innovation and commitment to scientific excellence make him a true pioneer in the field.

This text is generated by artificial intelligence and may not be accurate.